These five top short squeeze stocks are worth a close look from retail investors looking for opportunities in an otherwise down market. The post Short Squeeze Stocks: ISIG, PIXY and 3 Others Experts T
Microbot Medical is a $50 million pre-revenue company that developed and owns its patented LIBERTY Robotics System. On December 27, 2021, the company signed a collaboration agreement with Stryker Corp
Health care stocks worth knowing as the Omicron Covid-19 variant sweeps the globe.

Why Microbot Medical Shares Are Sliding Today

12:20pm, Tuesday, 28'th Dec 2021
Microbot Medical Inc (NASDAQ: MBOT) is trading lower Tuesday as the stock pulls back following Monday's strength. Microbot Medical shares surged Monday after the company announced a strategic colla
Microbot Medical is catching investors' attention on Monday, with shares up more than 70% at one point during the day. Here's why.
HINGHAM, Mass., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical t
The stock price of Microbot Medical Inc (NASDAQ: MBOT) increased by over 50% pre-market today. This is why it happened.
HINGHAM, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a th
HINGHAM, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has and will continue to implement key initiatives that will prepare the LIBERTY® Robotic Sy
HINGHAM, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has and will continue to implement key initiatives that will prepare the LIBERTY® Robotic System for commercialization. In conjunction with recently announced design freeze, Dr. Eyal Morag, Microbots Chief Medical Officer, traveled to the United States to establish a clinical infrastructure with multiple sites and leading physicians for the commencement of a human clinical trial, which is expected to commence in the second half of 2022.
Live Demonstration of the LIBERTY Robotic System is Planned for January 10th in San Francisco, CA Live Demonstration of the LIBERTY Robotic System is Planned for January 10th in San Francisco, CA
Live Demonstration of the LIBERTY Robotic System is Planned for January 10th in San Francisco, CA Live Demonstration of the LIBERTY Robotic System is Planned for January 10th in San Francisco, CA
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE